Elizabeth Hellström

1.3k citations
10 papers · 949 · 2 hit papers · h-index 8

Impact in

    • Tuberculosis Research and Epidemiology
    • SARS-CoV-2 and COVID-19 Research
    • HIV/AIDS Research and Interventions
  • Immunology top 10%
    • Immune responses and vaccinations
    • Immunodeficiency and Autoimmune Disorders

Papers in

    • Tuberculosis Research and Epidemiology 3
    • HIV/AIDS drug development and treatment 2
    • Reproductive tract infections research 2

Elizabeth Hellström

9 papers receiving 928 citations

Elizabeth Hellström's Hit Papers

Final Analysis of a Trial of M72/AS01 E Vaccine to Prevent Tuberculosis 2019 · 416 citations
4160+2+5Years since publication100200300400

Peers

Elizabeth Hellström
Comparison fields: 5 of 63
  • Infectious Diseases 728
  • Immunology 349
  • Epidemiology 274
  • Microbiology 38
  • Virology 27
Replace Anne Bollaerts with:
Anne Bollaerts Belgium
Elana van Brakel South Africa
David L. Lakey United States
Gro Ellen Korsvold Norway
Simbarashe Mabwe South Africa
Joseph John Zeppa Canada
Kathryn Tucker Rutkowski United States
Asma Toefy South Africa
Patrick Kwasi Owiafe Gambia
Liya Wassie Ethiopia
Elizabeth Hellström relative to Anne Bollaerts Belgium Anne Bollaerts's profile →
Citations per field
00.5×1.5×2.1×
Anne Bollaerts · 1×
Citations per year

Countries citing papers authored by Elizabeth Hellström

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Hellström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Hellström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Hellström more than expected).

Fields of papers citing papers by Elizabeth Hellström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Hellström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Hellström. The network helps show where Elizabeth Hellström may publish in the future.

Co-authors

The 25 scholars most cited alongside Elizabeth Hellström, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elizabeth Hellström Line = papers co-authored together Elizabeth Hellström links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1
Final Analysis of a Trial of M72/AS01 E Vaccine to Prevent Tuberculosis
Hit paper breakdown →
2019416
2
Phase 2b Controlled Trial of M72/AS01 E Vaccine to Prevent Tuberculosis
Hit paper breakdown →
2018320
3 2016101
4 201855
5 202521
6 201113
7 201813
8 20249
9 20181
10 20250

About Elizabeth Hellström

Elizabeth Hellström is a scholar working on Infectious Diseases, Microbiology, Epidemiology, Molecular Biology and Insect Science, having authored 10 papers that have together received 949 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (3 papers), HIV/AIDS drug development and treatment (2 papers), Reproductive tract infections research (2 papers), Mycobacterium research and diagnosis (1 paper) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Infectious Diseases (728 citations), Immunology (349 citations), Epidemiology (274 citations), Microbiology (38 citations) and Virology (27 citations). Elizabeth Hellström has collaborated with scholars based in South Africa, United States and Netherlands. Frequent co-authors include Annalene M. Nel, Cheryl Emily Louw, Linda‐Gail Bekker, Philip Kotze, Elizabeth Montgomery, Ariane van der Straten, Elizabeth Anne Bukusi, Cynthia Woodsong, Neliëtte van Niekerk and Francis E. A. Martinson. Their work appears in journals such as New England Journal of Medicine, PLoS ONE, The International Journal of Tuberculosis and Lung Disease, Open Forum Infectious Diseases and The Lancet HIV.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact